Trial Profile
Assessment of Atrial Late Potentials in Patients with Hypercholesterolemia, to Investigate the Preventive Effect of Pitavastatin on Atrial Fibrillation.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Ezetimibe; Fenofibrate
- Indications Atrial fibrillation; Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms ALPINA
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
- 08 Mar 2011 New trial record